title: Stimulants, narcotics and beta-blockers: 25 years of development in analytical techniques for doping control.
abstract: More than 25 years of developing doping control methods have led to comprehensive screening and confirmation procedures for stimulants, narcotics and beta-blockers. Much of this work has been initiated and/or improved by the late Prof. Dr. Manfred Donike. The methodological approach covered in this overview was applied to doping control procedures during the XXV Summer Olympics in Barcelona, Spain, in 1992 and the XVII Winter Olympics in Lillehammer, Norway, in 1994. Urine samples are screened through a combination of two analytical methods that are complementary: (a) gas chromatographic analysis of the parent compound and unconjugated metabolites, following single-step sample extraction and detection by a nitrogen-specific detector based on a retention index identification system and (b) gas chromatographic analysis including also conjugated drugs and metabolites after hydrolysis, solid-phase extraction, derivatisation and mass spectrometric detection. Confirmation and identification is always performed by gas chromatographic separation and full scan mass spectrometric detection. These methods facilitate the rapid screening and confirmation of more than 100 stimulants, narcotic analgesics and beta-blockers in urine for at least 24 h after the intake of a pharmaceutical dose. Application of the methods ensures high quality standards for the unequivocal identification of doping agents as well as a rapid turnaround time for sample analyses.
authors.affiliation: Hormone Laboratory, Aker Hospital, Oslo, Norway.
authors.forename: P
authors.initials: P
authors.lastname: Hemmersbach
authors.forename: R
authors.initials: R
authors.lastname: de la Torre
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000652:urine*; D000697:Central Nervous System Stimulants / Q000652:urine*; D002845:Chromatography / Q000379:methods; D004300:Doping in Sports / Q000517:prevention & control*; D008401:Gas Chromatography-Mass Spectrometry; D006801:Humans; D009294:Narcotics / Q000652:urine*; D015813:Substance Abuse Detection
chemical_list: D000319:Adrenergic beta-Antagonists; D000697:Central Nervous System Stimulants; D009294:Narcotics